Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Knösel

Showing results (111-120 of 188) with videos related to

Pageof 19
Sort By:
BMC Cancer|June 15, 2019
Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumorsFlorian Bösch, Alexandr V Bazhin, Sabine Heublein, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 18, 2019
Classification of microadenomas in patients with primary aldosteronism by steroid profilingYuhong Yang, Jacopo Burrello, Alessio Burrello, et al.
Surgical Oncology|April 26, 2023
Diagnostic accuracy of biopsy after neoadjuvant treatment for well-differentiated and dedifferentiated retroperitoneal liposarcomaLukas Gold, Christian Moser, Matthias P Fabritius, et al.
Cancers|February 25, 2022
VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?Markus Albertsmeier, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Cancers|October 13, 2021
Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based ChemotherapyLuc M Berclaz, Annelore Altendorf-Hofmann, Hans Roland Dürr, et al.
Frontiers in Endocrinology|March 25, 2025
Wnt/β-catenin pathway activation is associated with glucocorticoid secretion in adrenocortical carcinoma, but not directly with immune cell infiltrationTanja Maier, Laura-Sophie Landwehr, Alexandra Triebig, et al.
Cancer Metastasis Reviews|November 26, 2024
Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactionsTina Frankenbach-Désor, Isabella Niesner, Parveen Ahmed, et al.
Sarcoma|March 20, 2020
Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue SarcomaVeit Bücklein, Christina Limmroth, Eric Kampmann, et al.
Hypertension (Dallas, Tex. : 1979)|May 24, 2021
Single-Center Prospective Cohort Study on the Histopathology, Genotype, and Postsurgical Outcomes of Patients With Primary AldosteronismLucie S Meyer, Laura Handgriff, Jung Soo Lim, et al.
Cancers|June 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Pageof 19

Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
BMC Cancer|June 15, 2019
Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumorsFlorian Bösch, Alexandr V Bazhin, Sabine Heublein, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 18, 2019
Classification of microadenomas in patients with primary aldosteronism by steroid profilingYuhong Yang, Jacopo Burrello, Alessio Burrello, et al.
Surgical Oncology|April 26, 2023
Diagnostic accuracy of biopsy after neoadjuvant treatment for well-differentiated and dedifferentiated retroperitoneal liposarcomaLukas Gold, Christian Moser, Matthias P Fabritius, et al.
Cancers|February 25, 2022
VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?Markus Albertsmeier, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Cancers|October 13, 2021
Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based ChemotherapyLuc M Berclaz, Annelore Altendorf-Hofmann, Hans Roland Dürr, et al.
Frontiers in Endocrinology|March 25, 2025
Wnt/β-catenin pathway activation is associated with glucocorticoid secretion in adrenocortical carcinoma, but not directly with immune cell infiltrationTanja Maier, Laura-Sophie Landwehr, Alexandra Triebig, et al.
Cancer Metastasis Reviews|November 26, 2024
Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactionsTina Frankenbach-Désor, Isabella Niesner, Parveen Ahmed, et al.
Sarcoma|March 20, 2020
Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue SarcomaVeit Bücklein, Christina Limmroth, Eric Kampmann, et al.
Hypertension (Dallas, Tex. : 1979)|May 24, 2021
Single-Center Prospective Cohort Study on the Histopathology, Genotype, and Postsurgical Outcomes of Patients With Primary AldosteronismLucie S Meyer, Laura Handgriff, Jung Soo Lim, et al.
Cancers|June 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Pageof 19